1. | Takkar L, Lal V. Idiopathic intracranial hypertension: The monster within. Ann Indian Acad Neurol 2020;23:159-66. [Full text] |
2. | Chen JJ, Trobe JD. Optical coherence tomography should be used routinely to monitor patients with idiopathic intracranial hypertension. J Neuroophthalmol 2016;36:453-9. |
3. | Chen JJ, Thurtell MJ, Longmuir RA, Garvin MK, Wang JK, Wall M, et al. Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest Ophthalmol Vis Sci 2015;56:3850-9. |
4. | Kumar N, Tigari B, Dogra M, Singh R. Successful management of peripaillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab. Indian J Ophthalmol 2018;66:1358-60.  [ PUBMED] [Full text] |
5. | Ozgunul C, Moinuddin O, Munie M, Lee MS, Bhatti MT, Landu K. Management of peripapillary choroidal neovascular membrane in patients with idiopathic intracranial hypertension. J Neuroophthalmol 2019;39:451-7. |
6. | Loo KGB, Lim SA, Lim ILZ, Chan DWS. Guiding follow up of pediatric intracranial hypertension with optic coherence tomography. BMJ Case Rep 2016;2016:bcr2015213070. |